Voyager Therapeutics, Inc.
VYGR· Nasdaq
VYGRVoyager Therapeutics, Inc.
Filed Dec 17, 2015 · 10-Q · 78 days after period end · 0001558370-15-002867
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | $4.94M | — |
| Net Income | -$3.92M | -$4.01M |
| EPS Diluted | $5.25 | $6.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Dec 17, 2015 · 78 d after period end
